eXmoor Pharma and UCL establish strategic cell and gene therapy collaboration
Cell and gene therapies are often delayed by technical and regulatory issues
Read More
Tag: UCL
UCL researchers launch congenital muscular dystrophy research programme
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Read More
Parkinson’s UK partners with UCL on phase II trial
Trial will investigate chemotherapy drug to alleviate hallucinations in people with Parkinson’s
Read More
Corticosteroids boost survival rates for COVID-19 patients
Four papers have been published reinforcing evidence that steroids can significantly improve the outcomes for those critically ill with the virus
Read More
Clinical research cut 87% at peak of pandemic
The model suggests that just 13% of full-time academics would have been available to carry out research during the height of the pandemic
Read More
UCL start-up Novai raises £500,000 for AI tech
The funds will be used to further developed tech that enables earlier detection of eye disease
Read More
UCLB, Apollo secure first licensing deal with US investment powerhouse
Deerfield is partnering on the development of a novel gene therapy
Read More
Researchers develop AI tool able to predict cancer relapse
Researchers are hopeful that this ‘ground-breaking approach’ could accelerate the prediction of which patients are more at risk of their disease returning
Read More
Scientists develop revolutionary tech to improve prostate cancer detection
A ‘revolutionary’ new medical software able to pinpoint the area from which surgeons should take a biopsy to detect prostate cancer has been developed by NIHR supported researchers.
Read More
First Alzheimer’s drug from Eisai/UCL alliance to enter clinical trials
The first drug candidate from Eisai and University College London (UCL)’s drug discovery collaboration is to enter Phase I clinical trials for Alzheimer’s disease (AD) early next year.
Read More
Lilly streams £5m into virtual lab pact with UCL, Imperial
Imperial College London, UCL and Eli Lilly have formed an alliance that strives to transform medicines manufacturing in England.
Read More
Study finds widespread belief in “mythical” causes of cancer
Research led by University College London (UCL) and the University of Leeds, with support from a Cancer Research UK/Bupa Foundation Innovation Award, has revealed widespread public belief in “mythical causes” of cancer.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
